Efficacy and Safety of Three Different Aflibercept Regimens in Subjects With Diabetic Macular Edema (DME)
NCT02818998
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
463
Enrollment
INDUSTRY
Sponsor class
Conditions
Macular Edema
Interventions
DRUG:
Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
Sponsor
Bayer